Skip Over Navigation Links

Maximizing Investigators' Research Award (MIRA) (R35)

MIRA provides support for the research in an investigator's laboratory that falls within the mission of NIGMS. The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding by providing investigators with greater stability and flexibility, thereby enhancing scientific productivity and the chances for important breakthroughs. The program will also help distribute funding more widely among the nation's highly talented and promising investigators. MIRA grants will generally be for 5 years for both established investigators and new and early stage investigators. The program is now expanding beyond the pilot testing phase, with eligibility expanded to investigators renewing GM R01 equivalent grants with PAR-17-094. In 2017, a new FOA will be issued for ESIs.

Maximizing Investigators’ Research Award (R35)

Maximizing Investigators' Research Award for Early Stage Investigators (R35)

For more information about MIRA or ESI-MIRA, contact Dr. Vernon Anderson at 301-594-3827 or Dr. Kristine Willis at 301-594-0943.

NIH Definitions of New and Early Stage Investigators, Policies, and Procedures

MIRA Current and Pending Support Model Attachment [PDF, 47KB] (Required - updated)

New NIH Biosketch and Sample (Required)​​​​​​​​​​​​​​​​​​

This page last reviewed on February 17, 2017